Furuta Kenjiro, Ito Akihiro, Ishida Tadashi, Ito Yuhei, Sone Naoyuki, Takaiwa Takuya, Yokoyama Toshihide, Tachibana Hiromasa, Arita Machiko, Hashimoto Toru
Department of Respiratory Medicine, Kobe City Hospital Organization Kobe City Medical Center West Hospital, 2-4 Ichibancho, Nagata-ku, Kobe, Hyogo 653-0013, Japan; Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan.
Department of Respiratory Medicine, Ohara Memorial Kurashiki Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan.
J Infect Chemother. 2016 Sep;22(9):622-8. doi: 10.1016/j.jiac.2016.06.009. Epub 2016 Jul 16.
It can be difficult to treat respiratory tract infections caused by Mycobacterium abscessus (M. abscessus) as there is no established treatment strategy. Complications involving other nontuberculous mycobacterial infections such as Mycobacterium avium complex (MAC) are also commonly observed.
We investigated the clinical background and course of 18 cases of pulmonary M. abscessus infection treated over 8 years at Kurashiki Central Hospital. Radiological evaluation was performed using NICE scoring system, a method of semi-quantitative evaluation of imaging findings of pulmonary MAC infection.
The mean age of the 18 patients (males, 6; females, 12) was 74.7 years. The median follow-up period was 1316 days (95% confidence interval; 720-1675 days), and 11 patients were concomitantly infected with pulmonary MAC. Among the patients that underwent antibacterial treatment for M. abscessus, there was one MAC-complication case and one non-MAC-complication case. All MAC-complication cases underwent antibacterial treatment including clarithromycin. Chest X-ray NICE scores for all cases were 8.50 ± 5.45 and 10.94 ± 6.03 at baseline and follow-up, respectively (p = 0.0063). For MAC-complication cases, scores were 8.36 ± 4.74 and 12.00 ± 6.02 at baseline and follow-up, respectively (p = 0.00818), and for non-MAC-complication cases, scores were 8.71 ± 6.82 and 9.29 ± 6.13 at baseline and follow-up, respectively (p = 0.356). MAC-complication cases were significantly further exacerbated than non-MAC-complication cases (p = 0.027).
Some cases of pulmonary M. abscessus infection progressed well without undergoing antibacterial treatment. In particular, results suggested that the clinical course of MAC-complication and non-MAC-complication cases differs.
由于缺乏既定的治疗策略,脓肿分枝杆菌(M. abscessus)引起的呼吸道感染可能难以治疗。涉及其他非结核分枝杆菌感染(如鸟分枝杆菌复合群,MAC)的并发症也很常见。
我们调查了仓敷中央医院8年间治疗的18例肺脓肿分枝杆菌感染患者的临床背景和病程。使用NICE评分系统进行影像学评估,这是一种对肺MAC感染影像学表现进行半定量评估的方法。
18例患者(男性6例,女性12例)的平均年龄为74.7岁。中位随访期为1316天(95%置信区间:720 - 1675天),11例患者同时合并肺MAC感染。在接受脓肿分枝杆菌抗菌治疗的患者中,有1例MAC并发症病例和1例非MAC并发症病例。所有病例胸部X线NICE评分在基线时和随访时分别为8.50±5.45和10.94±6.03(p = 0.0063)。对于MAC并发症病例,基线时和随访时的评分分别为8.36±4.74和12.00±6.02(p = 0.00818),对于非MAC并发症病例,基线时和随访时的评分分别为8.71±6.82和9.29±6.13(p = 0.356)。MAC并发症病例比非MAC并发症病例明显恶化更严重(p = 0.027)。
一些肺脓肿分枝杆菌感染病例未经抗菌治疗也进展良好。特别是,结果表明MAC并发症病例和非MAC并发症病例的临床病程不同。